The contribution of venous return to the increase in anaerobic threshold (AT) in patients with acute myocardial infarction (AMI) was investigated. Twenty-seven patients with uncomplicated AMI underwent supine and sitting cardiopulmonary exercise testing, and 10 out of these 27 patients performed constant-workload tests in which cardiac output before and after a phase II program was measured. Data from 8 patients were eliminated because of restenosis after direct percutaneous transluminal coronary angioplasty. The increase in AT was significantly greater in the sitting position than in the supine position, 15.0±9.9% and 6.3±6.0% respectively. Average O2 pulse at AT changed non-significantly from 8.6±1.5 to 8.7±1.2 ml min -1 beat -1 in the supine position, but it showed a significant increase from 8.1±1.3 to 9.2±1.3 ml min -1 beat -1 when mesured in the sitting position. In the constant-workload studies, stroke index showed a significant increase during both supine and sitting exercise. Percent increase in the stroke index from rest to exercise did not differ significantly in the supine position, but did differ significantly in the sitting position. These results strongly suggest that increased venous return as well as improvement in cardiac pump function play a major role in the mechanism of AT increase in an upright position throughout the recovery phase in AMI patients. (Jpn Circ J 1999; 63: 261 -266) 
naerobic threshold (AT) is now widely evaluated because of its strong correlation with peak oxygen uptake (V • O2) 1 and with clinical symptoms. 2 It is also used in exercise prescription for cardiac patients because of its efficacy as a measure of exercise intensity 3 and its potential to prevent excessive cardiac stress as defined by the ejection fraction. 4, 5 It has previously been reported that, among patients recovering from acute myocardial infarction (AMI) who do not manifest an ischemic ECG during exercise stress testing, a significant increase in AT as well as peak V
• O2 is exhibited by those who undergo supervised exercise training at AT levels compared with patients who do not undergo such training. 3 The increase in AT was similar to the increase in peak V
• O2 in each group. Although we found that exercise training could increase AT as well as peak V
• O2, the mechanism of increase in AT remains unknown.
Several mechanisms appear to contribute to an increase in AT during the recovery phase of AMI. One of these is the recovery of cardiac pump function, especially in patients who have been successfully treated by either percutaneous transluminal coronary angioplasty (PTCA) or thrombolysis therapy. Although wall motion abnormalities usually recover within a few days after treatment, 6 this recovery may be delayed. 7 Angiotensin-converting enzyme (ACE) inhibitors have been reported to prevent ventricular remodeling, which may also lead to reduction in a patient's exercise capacity. 8 Muscle strengthening exercises might also increase AT, 9 but the relationship between muscle strength and peripheral muscular blood flow has not been thoroughly investigated.
Another major factor is improvement in cardiovascular deconditioning as a result of prolonged bed rest or inactivity after a heart attack. Several investigations have shown decreased stroke volume to be the primary factor in that mechanism. 10, 11 In addition, Convertino et al 11 have reported that decreased venous return plays a major role in the reduction of stroke volume, which is attributable to a much greater decrease in peak V
• O2 during upright exercise than during supine exercise in normal subjects. Although Convertino et al did not measure AT, intolerance to orthostatic stress was shown to be a key factor in deconditioning in normal subjects.
This study was designed to investigate the contribution of venous return to the increase in AT in patients in the recovery phase of AMI by testing the hypothesis that changes in AT are smaller in magnitude when a patient is in a supine position than in a sitting one.
Methods

Subjects
Twenty-seven male patients who had been hospitalized immediately after the onset of AMI and had completed an inpatient cardiac rehabilitation program (phase I) were enroled in this study. All patients underwent direct PTCA and suffered no acute complications, but 8 of the 27 patients were eliminated from the study because of significant restenosis (≥75% of normal coronary diameter) of the PTCA regions, as revealed by comparing selective coronary angiograms taken 1 and 3 months after onset. The Japanese Circulation Journal Vol.63, April 1999 average age of the remaining patients was 55.3±7.8 years, height was 165.0±7.9 cm, and weight was 64.8±6.8 kg before training and 63.8±6.5 kg after training. The average value of peak creatine kinase (CK) was 3265±1947 IU/L. Of the 19 patients remaining in the study, 16 had singlevessel disease and 3 had double-vessel disease. All patients were taking ACE inhibitors and platelet-active drugs, 16 patients were taking nitrate, 9 patients were taking calcium channel blockers, and 5 patients were taking beta blockers. Medication was maintained at the same dose in each patient throughout the study.
Exercise Program
Phase I of the cardiac program consisted in early mobilization after 2-3 days of complete bed rest immediately after the onset of AMI, and an increase in ward activities over 1 week. In addition, stretching exercises and treadmill walking for gradually increasing durations (up to 30 min) at 3.2 km/h were performed in a rehabilitation gymnasium for 2 weeks. The cardiac exercise program for recovery phase (phase II) was performed for 8 weeks after the phase I program, with the patients using a treadmill or bicycle ergometer for 30-40 min 3 times a week, and the target heart rate at the individual's AT was achieved by a treadmill cardiopulmonary exercise test 1 month after AMI onset. Muscle strength training was also conducted at an intensity of 50% of the single repetition maximum, with 6 sets of 5 repetitions for knee extensions and for calf raises.
Cardiopulmonary Exercise Testing
After giving informed consent, each patient underwent cardiopulmonary exercise testing on an electromagnetically braked ergometer (Space cycle SSR, TS Health Systems, Tokyo) in both supine and sitting positions with a backrest, at 1 month and 3 months after onset, ie, before and after the 8 weeks of the phase II program (Fig1). For the supine test, the seat and backrest of the ergometer were set to horizontal, the crank axis was 30 cm above the seat, the shoulders stabilized and the feet fixed by forefoot loops and elastic bandaging. For the sitting test, the upper part of the ergometer was tilted upwards (backrest inclined 20°from vertical) and the seat was tilted down to its mechanical maximum. The supine and sitting tests were performed within 3 days of each other. The initial test was set alternately, and an AB-BA design was used to carry out the remaining tests for each patient. Exercise was performed with the initial work rate set at 10 W for 3 min and a pedaling rate of 50 rpm. The work rate was increased in 10-W increments every minute until the patient suffered fatigue. The same protocol was used for both supine and sitting tests. To accustom the patient to pedaling in each position, he pedaled for 5min at 10 W in each position on the day before the first test.
A 12-lead electrocardiogram and the heart rate (HR) were monitored throughout the testing via a stress test system (ML5000, Fukuda Denshi, Tokyo), and blood pressure (BP) was measured every minute by an indirect automatic manometer (Stress Test Blood Pressure Monitor STBP780, Colin, Aichi). Perception of physical effort at each stage was obtained separately for chest and legs using Borg's 6-20 numeric scale. Respiratory gas analysis was performed throughout the test using an Aero Monitor AE-280 (Minato Medical Science Ltd, Osaka), consisting of a zirconia oxygen analyzer, an infrared carbon dioxide analyzer and a hot wire spirometer. The system was carefully calibrated before each study. Oxygen uptake (V • O2), carbon dioxide output (V • CO2) and expired tidal volume were measured continuously on a breath-by-breath basis. Derived parameters such as minute ventilation (V • E), ventilatory equivalent of oxygen (V • E/V • O2), and respiratory gas exchange ratio (GER) were computed in real time, and were displayed with heart rate and V
• O2 on a monitor during measurement using a personal computer (NEC PC-9821, Tokyo). AT was determined from gas exchange data by the V-slope method 12 using our software, which determines the turning point of the V • O2-V • CO2 relation curve by 2 linear regression lines. Peak V
• O2 was defined as the average V
• O2 over the last 30 s of each test. Oxygen pulse at AT and at peak exercise was calculated using V
• O2 and heart rate at each point.
Constant Workload Testing and Cardiac Output Measurement
Ten out of the 28 patients performed a constant-workload test, on a different day from both the supine and the sitting cardiopulmonary exercise testing, to measure cardiac output at rest and during exercise in each position before and after the phase II program. Data from 3 out of these 10 patients were eliminated in this study because of restenosis in direct PTCA regions. For the remaining 7 patients, the average age was 59.3±6.5 years, height was 167.0±9.0 cm, and weight was 67.2±9.2 kg before training and 66.7±8.4 kg after training; the average value of peak CK was 2484± 1117 IU/L. Of these 7 patients, 6 had single-vessel disease and 1 had double-vessel disease. All patients were taking ACE inhibitors and platelet-active drugs, 4 were taking nitrate, 3 were taking calcium channel blockers and 2 were taking beta blockers. Medication was maintained at the same dose in each patient throughout the study.
Each patient assumed a supine position for 10 min before the testing, and performed a constant-workload test for 10 min at 30 W that did not exceed the AT determined 1 month after AMI. After a 5-min recovery, the position was shifted to sitting, which the patient assumed for an additional 10 min, and then the sitting test was performed at the same workload as the supine test (Fig 2) .
Cardiac output during exercise was measured by a dye dilution technique with indocyanin green, using a specialpurpose computer (Cardiac Output Computer MCL4200, Nihon Koden, Tokyo). Cardiac output was measured at rest (2-3 min before exercise) and during exercise (6 min after exercise onset), in both the supine and the sitting positions, by injection of 5 mg of indocyanin green diluted in 2ml of distilled water through a Teflon catheter inserted into the cubital vein. HR, BP and V
• O2 at rest and during exercise were measured in the same way as during cardiopulmonary exercise testing. During exercise in both positions, derived parameters were calculated, such as stroke volume index (SI) at rest and during exercise, percent increase in SI from rest to exercise [%∆SI ex-rest: (SI during exercise -SI at rest) / SI at rest], arteriovenous oxygen difference (a-v O2 difference; obtained using Fick's formula), and systemic vascular resistance [SVR: (mean BP/ cardiac index) × 1332].
Statistical Analysis
Wilcoxon tests were used to compare values before and after training in the same position, and Mann-Whitney tests were used to compare data between the supine and the Tables 1 and 2 show mean values of cardiorespiratory variables for both before and after training, and ratings of perceived exertion (RPE) during the supine and sitting cardiopulmonary exercise tests. Table 3 shows V
Results
• O2, HR, systolic BP (SBP), SI, %∆SI ex-rest, a-v O2 difference and SVR during the supine and the sitting constant workload tests.
Changes in Supine and Sitting Cardiopulmonary Tests
The average value of exercise duration to AT as well as to the peak of exercise significantly increased in both supine and sitting tests. The maximal responses of HR, SBP, rate pressure product (RPP), GER and the RPE score showed no significant changes in either supine or sitting tests, except for RPE in the legs during the sitting test.
AT increased significantly in both tests, from 12.6±2.2 to 13.3±1.9 ml min -1 kg -1 in the supine position and from 12.7±1.8 to 14.6±2.6 ml min -1 kg -1 in the sitting position. Peak V
• O2 also significantly increased in both positions, from 19.0±3.4 to 20.9±3.7 ml min -1 kg -1 in the supine test and from 19.4±3.1 to 22.6±3.5 ml min -1 kg -1 in the sitting test. Percent change in AT was significantly greater in the sitting test than in the supine one (15.0±9.9% compared with 6.3±6.0%), whereas percent change in peak V
• O2 did not significantly differ between the positions (17.0±11.9% in the sitting test and 11.0±11.3% in the supine test).
Average O2 pulse at AT did not show any significant increase during supine cardiopulmonary testing (from 8.6±1.5 to 8.7±1.2 ml min -1 beat -1 ), but it increased significantly in the sitting test (from 8.1±1.3 to 9.2±1.3 ml min -1 beat -1 ). Percent change in O2 pulse at AT was significantly greater in the sitting position than in the supine position (11.8±11.8% compared with 2.2±7.4%). Peak O2 pulse showed significant increases in both positions, from 10.0±2.0 to 10.6±1.9 ml min -1 beat -1 when the patient was supine and from 9.6±1.8 to 10.7±1.6 ml min -1 beat -1 when the patient was sitting. Percent change in peak O2 pulse did not differ significantly between the positions (9.5±16.9% when sitting and 7.3±12.4% when supine).
Changes in Cardiac Output in Supine and Sitting Constant-Workload Tests
Average HR at rest and during exercise decreased significantly in both positions. SI at rest and during exercise in the supine position and SI during exercise in the sitting position increased significantly, but the SI at rest in the sitting position did not (Table 3 ). Percent increase in SI from rest to exercise did not differ significantly over time in the supine position, but it did differ significantly in the sitting position (from 28.0±21.1% to 23.5±17.0% when supine and from 42.9±18.6% to 56.4±8.3% when sitting). No significant changes in any other variables were found.
Discussion
To quantify the contribution of venous return to the increase in AT in the recovery phase of AMI, changes in cardiorespiratory variables during supine exercise were compared with those during sitting exercise. The hypothesis that the magnitude of those changes in AT while supine are much smaller than while sitting was clearly supported. AT increased by only 6.3% during supine exercise, whereas it rose by 15% during sitting exercise. Moreover, the average O2 pulse at AT in the supine position remained approximately the same throughout the study period, whereas the O2 pulse at AT while sitting significantly increased by 11.8%. Before the phase II program, AT had approximately the same value in both positions. The average exercise time to AT in the supine position was higher than in the sitting position, but this relationship was reversed after that program period. A similar pattern was seen in the change of O2 pulse at AT. However, our previous report showed that AT and exercise time to AT were significantly higher with sitting than with supine exercise in normal subjects. 13 These findings are also in agreement with a study of patients with congestive heart failure. 14 Taking into consideration these reports and the postural effect on O2 pulse at AT before the phase II program in this study, it is suggested that an inadequate response to gravity stress during exercise led to a shorter exercise time to AT and lowered AT in the sitting position.
There is general agreement concerning postural effects on the mechanism of increase in stroke volume. Although the Frank-Starling mechanism mainly contributes to an increase in stroke volume rather than to augmentation in the left ventricular ejection fraction (LVEF) under supine exercise, both the Frank-Starling mechanism and augmentation in the LVEF contribute to increased stroke volume during sitting exercise in normal subjects. 15, 16 Among our findings, the O2 pulse at AT, in particular, points to a greater venous return or LVEF during exercise in the sitting position throughout the phase II program. However, the central or peripheral factor primarily responsible for the increase in O2 pulse at AT remains uncertain because the O2 pulse has been thought to reflect both stroke volume and peripheral O2 extraction. To gain a better understanding of this problem, we next examined stroke volume during constant workload.
In the constant-workload tests, HR during exercise significantly decreased after the phase II program, whereas SI significantly increased and a-v O2 difference and systemic vascular resistance remained unchanged in both the supine and sitting positions. A significant increase in SI, especially in supine studies, suggests an improvement in cardiac pump function because venous return during supine exercise appears not to have changed throughout the phase II program. Several reports show a direct effect of exercise on myocardial perfusion 17 and contractile function 18 in cardiac patients. However, these studies included patients with myocardial ischemia, and they involved more intense and prolonged training that was recognized to improve ventricular function. 19, 20 In contrast, the subjects in the present study showed no ischemic ECG changes during exercise testing, and trained only for 8 weeks at lesser intensity than the patients in previous reports. It is, thus, difficult to assume a direct effect of exercise training on left ventricular function leading to increased stroke volume and AT in the present study. Instead, the improvement in ventricular function due to recanalization by direct PTCA could have occurred throughout the phase II program because none of the subjects in this study manifested restenosis after that period. 7, 21 The significant increase in peak V • O2 as well as in peak O2 pulse in both positions, taken together with the findings on SI in the supine studies, suggest improvement in cardiac function. Although Koike et al. 22 have reported that V
• O2 response at the onset of exercise reflects cardiac function rather than peak V
• O2 in patients with myocardial infarction, the increase in peak V
• O2 measured with the muscles untrained or otherwise trained has generally been attributed to central circulatory adaptation. 23, 24 In addition, maximal cardiac output generally determines peak V
• O2. 25 It is difficult to take into consideration peripheral adaptations during supine exercise because all of the subjects trained upright during the phase II program.
In addition to the improvement in ventricular function, the greater increase in SI from rest to exercise in a sitting position than in a supine one suggests that an increased preload may be added that could contribute to increased stroke volume during sitting exercise after convalescence.
The data that show a significant increase in SI of approximately 10% under supine constant workload, however, do not appear to corroborate the data of O2 pulse at AT under supine cardiopulmonary testing, which remained unchanged over time. Although peripheral O2 extraction may have diminished its ratio to O2 pulse at AT throughout the phase II program for the supine position, the present study does not allow clarification of the precise relationship because the constant workload was set at 30 W rather than at the patient's own AT level. Further study is needed to examine this relationship.
In conclusion, this study strongly suggests that improved venous return and improvement in cardiac pump function play a major role in the mechanism of AT increase in an upright position throughout the recovery phase in patients with AMI who undergo successful direct PTCA.
